G

GI Innovation Inc
KOSDAQ:358570

Watchlist Manager
GI Innovation Inc
KOSDAQ:358570
Watchlist
Price: 8 440 KRW -8.46% Market Closed
Market Cap: 373.9B KRW
Have any thoughts about
GI Innovation Inc?
Write Note

GI Innovation Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GI Innovation Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
G
GI Innovation Inc
KOSDAQ:358570
Income from Continuing Operations
-â‚©55.5B
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Income from Continuing Operations
â‚©183.8B
CAGR 3-Years
-31%
CAGR 5-Years
-5%
CAGR 10-Years
6%
SK Bioscience Co Ltd
KRX:302440
Income from Continuing Operations
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Income from Continuing Operations
â‚©119.4B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Income from Continuing Operations
â‚©88.1B
CAGR 3-Years
22%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Income from Continuing Operations
-â‚©5.1B
CAGR 3-Years
41%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

GI Innovation Inc
Glance View

Market Cap
373B KRW
Industry
Biotechnology

GI Innovation, Inc. engages in the development of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 88 full-time employees. The company went IPO on 2023-03-30. The firm is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.

Intrinsic Value
9 532.34 KRW
Undervaluation 11%
Intrinsic Value
Price
G

See Also

What is GI Innovation Inc's Income from Continuing Operations?
Income from Continuing Operations
-55.5B KRW

Based on the financial report for Dec 31, 2023, GI Innovation Inc's Income from Continuing Operations amounts to -55.5B KRW.

What is GI Innovation Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
10%

Over the last year, the Income from Continuing Operations growth was 30%. The average annual Income from Continuing Operations growth rates for GI Innovation Inc have been 10% over the past three years .

Back to Top